Indian Air Force Security Medical Supplies Tender 2026 ISABGOL, L- Leucine & Related Drugs - Department of Military Affairs

Tender Overview

The Indian Air Force, Department of Military Affairs, seeks procurement related to a diverse range of pharmaceutical and medical items, spanning 17 total line items. The scope includes active pharmaceutical ingredients and packaged drugs such as L-leucine, L-valine, L-isoleucine sachets, ISABGOL husk powder, azelnidipine, gabapentin with lignocaine ointment, cilnidipine with telmisartan combinations, antiestrogens (letrozole, anastrozole), diuretics (chlorthalidone), antidiabetics (empagliflozin, dapagliflozin variants), insulin formulations, antihistamines, beta-blockers, dopaminergic agents, and oncology medications (imatinib). The BOQ lists 17 items but specific quantities and delivery scope are not disclosed, suggesting a framework purchase with potential bulk and phased delivery. The tender title is aligned to government procurement for a broad medical stockpile, with unique emphasis on pharmaceutical diversity and potential hospital/field medical support usage. Contextual differentiators include multi-category pharmaceutical procurement under a single tender and a focus on regulated drug categories. Unique aspects include the absence of explicit itemized specifications in the provided data and a requirement to align with IAF/DM-demanded medical supply protocols.

Technical Specifications & Requirements

• Product categories: diverse pharmaceuticals and medical supplies including L- leucine, L-valine, L-isoleucine sachet, ISABGOL husk powder, AZELNIDIPINE 8 MG, LIGNOCAINE with GABAPENTIN OINT, CILNIDIPINE 10 MG with TELMISARTAN 40 MG, LETROZOLE 2.5 MG, ANASTRAZOLE 1 MG, CHLORTHALIDONE 6.25 MG, EMPAGLIFLOZIN 25 MG, DAPAGLIFLOZIN/REMOGLIFLOZIN variants, VILDAGLIPTIN 100 MG, INSULIN (10 ML) INJ, HYOSCINE BROMIDE 10 MG, METOPROLOL XL 12.5 MG, NEBIVOLOL 2.5 MG, ROPINIROLE 0.5 MG, IMATINIB 400 MG.
• No explicit performance, dosage, or packaging specifications are provided within the tender data.
• Emphasis on regulatory alignment, potential ISI/ISO compliance not specified, and a requirement to submit under a government procurement framework for 17 items.
• Delivery, shelf-life, storage conditions, and validation/verification standards are not stated; bidders should seek ATC document and Buyer Uploaded ATC for further guidance.
• The lack of concrete quantities suggests a flexible procurement framework with possible future order placements and staged deliveries.

Terms, Conditions & Eligibility

• EMD/Financial security: Not disclosed in the provided data; bidders should review the ATC and Terms & Conditions uploaded by the buyer for exact security requirements.
• Experience: No explicit years or turnover thresholds provided; bidders must consult the Buyer Added Terms and Conditions and ATC document for eligibility criteria.
• Delivery timeline: No specific delivery window published; bidders should verify with the tender documents for delivery schedule and penalties, if any.
• Payment terms: Not specified in the data; review the buyer’s terms and conditions and ATC for payment schedule, milestones, and penalties.
• Submission documents: The tender references GST, PAN, experience certificates, financial statements, EMD, OEM authorizations; bidders must attach these per the Terms & Conditions and ATC.
• Warranty/AMC: Not defined in the data; confirm with official tender documents for after-sales service, warranty period, and service levels.
• Penalties: No LD terms disclosed here; bidders should verify LD provisions and performance bonds in the ATC/Terms.